{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:08:00Z","timestamp":1794344880019,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Swedish Heart and Lung foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The VisareNorr Fund\/Northern County Council\u2019s Regional Federation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Swedish Heart and Lung Association","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The County Council of Norrbotten","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The County Council of V\u00e4sterbotten","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"The Swedish Respiratory Society","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"King Gustaf V and Queen Victoria\u2019s Freemason Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004885","name":"Ume\u00e5 University","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004885","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["Butler Senior Clinical Research Fellowship FS\/16\/14\/32023"],"award-info":[{"award-number":["Butler Senior Clinical Research Fellowship FS\/16\/14\/32023"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Ischemic heart disease is common in COPD and associated with worse prognosis. This study aimed to investigate the presence and prognostic impact of biomarkers of myocardial injury and ischemia among individuals with COPD and normal lung function, respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In 2002\u201304, all individuals with airway obstruction (FEV<jats:sub>1<\/jats:sub>\/VC\u2009&lt;\u20090.70, <jats:italic>n<\/jats:italic>\u2009=\u2009993) were identified from population-based cohorts, together with age and sex-matched non-obstructive referents. At re-examination in 2005, spirometry, Minnesota-coded ECG and analyses of high-sensitivity cardiac troponin I (hs-cTnI) were performed in individuals with COPD (<jats:italic>n<\/jats:italic>\u2009=\u2009601) and those with normal lung function (<jats:italic>n<\/jats:italic>\u2009=\u2009755). Deaths were recorded until December 31st, 2010.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Hs-cTnI concentrations were above the risk stratification threshold of \u22655\u2009ng\/L in 31.1 and 24.9% of those with COPD and normal lung function, respectively. Ischemic ECG abnormalities were present in 14.8 and 13.4%, while 7.7 and 6.6% had both elevated hs-cTnI concentrations and ischemic ECG abnormalities. The 5-year cumulative mortality was higher in those with COPD than those with normal lung function (13.6% vs. 7.7%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Among individuals with COPD, elevated hs-cTnI both independently and in combination with ischemic ECG abnormalities were associated with an increased risk for death (adjusted hazard ratio [HR]; 95% confidence interval [CI] 2.72; 1.46\u20135.07 and 4.54; 2.25\u20139.13, respectively). Similar associations were observed also among individuals with COPD without reported ischemic heart disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study, elevated hs-cTnI concentrations in combination with myocardial ischemia on the electrocardiogram were associated with a more than four-fold increased risk for death in a population-based COPD-cohort, independent of disease severity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12931-020-01430-z","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T05:02:44Z","timestamp":1593147764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cardiac biomarkers of prognostic importance in chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2574-479X","authenticated-orcid":false,"given":"Ulf","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stridsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"R\u00f6nmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"crossref","unstructured":"Lamprecht B, Soriano JB, Studnicka M, et.al. Determinants of underdiagnosis of COPD in national and international surveys. Chest 2015;148:971\u2013985.","DOI":"10.1378\/chest.14-2535"},{"key":"1430_CR2","doi-asserted-by":"crossref","unstructured":"Lindberg A, Bjerg A, R\u00f6nmark E, et.al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the obstructive lung disease in northern Sweden studies. Respir Med 2006;100:264\u2013272.","DOI":"10.1016\/j.rmed.2005.04.029"},{"issue":"4","key":"1430_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1378\/chest.12-2847","volume":"144","author":"H M\u00fcllerova","year":"2013","unstructured":"M\u00fcllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163\u201378.","journal-title":"Chest"},{"key":"1430_CR4","doi-asserted-by":"crossref","unstructured":"Sin DD, Anthonisen NR, Soriano JB, et.al. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245\u20131257.","DOI":"10.1183\/09031936.00133805"},{"key":"1430_CR5","doi-asserted-by":"crossref","unstructured":"Roversi S, Fabbri LM, Sin DD, et.al. Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med 2016;194:1319\u20131336.","DOI":"10.1164\/rccm.201604-0690SO"},{"key":"1430_CR6","doi-asserted-by":"crossref","unstructured":"Singh D, Agusti A, Anzueto A, et.al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the gold science committee report 2019. Eur Respir J 2019;53:1900164.","DOI":"10.1183\/13993003.00164-2019"},{"key":"1430_CR7","doi-asserted-by":"crossref","unstructured":"Nilsson U, Blomberg A, Johansson B, et.al. Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease. Int J Chron Obstruct Pulmon Dis 2017;12:2507\u20132514.","DOI":"10.2147\/COPD.S136404"},{"key":"1430_CR8","doi-asserted-by":"crossref","unstructured":"Shah AS, McAllister DA, Mills R, et.al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 2015;128:493\u2013501.","DOI":"10.1016\/j.amjmed.2014.10.056"},{"key":"1430_CR9","doi-asserted-by":"crossref","unstructured":"Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54\u201361.","DOI":"10.1373\/clinchem.2011.165795"},{"key":"1430_CR10","doi-asserted-by":"crossref","unstructured":"Ford I, Shah AS, Zhang R, et.al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol 2016;68:2719\u20132728.","DOI":"10.1016\/j.jacc.2016.10.020"},{"key":"1430_CR11","doi-asserted-by":"crossref","unstructured":"Chapman AR, Lee KK, McAllister DA, et.al. Association of High-Sensitivity Cardiac Troponin I Concentration with Cardiac Outcomes in patients with suspected acute coronary syndrome. JAMA 2017;318:1913\u20131924.","DOI":"10.1001\/jama.2017.17488"},{"key":"1430_CR12","doi-asserted-by":"crossref","unstructured":"Shah AS, Anand A, Sandoval Y, et.al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015;386:2481\u2013248811.","DOI":"10.1016\/S0140-6736(15)00391-8"},{"key":"1430_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jacc.2018.06.051","volume":"72","author":"PD Adamson","year":"2018","unstructured":"Adamson PD, Anderson JA, Brook RD, et al. Cardiac troponin I and cardiovascular risk in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2018;72:1126\u201337.","journal-title":"J Am Coll Cardiol"},{"key":"1430_CR14","doi-asserted-by":"crossref","unstructured":"Pavasini R, d'Ascenzo F, Campo G, et.al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol 2015;191:187\u2013193.","DOI":"10.1016\/j.ijcard.2015.05.006"},{"key":"1430_CR15","doi-asserted-by":"crossref","unstructured":"H\u00f8iseth A D, Neukamm A, Karlsson B D, et.al. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 2011;66:775\u2013781.","DOI":"10.1136\/thx.2010.153122"},{"key":"1430_CR16","doi-asserted-by":"crossref","unstructured":"Waschki B, Zeller T, Neumann J, et.al. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study. Eur Respir J 2020; 55: 1901314.","DOI":"10.1183\/13993003.01314-2019"},{"issue":"Suppl1","key":"1430_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1752-699X.2008.00086.x","volume":"2","author":"A Lindberg","year":"2008","unstructured":"Lindberg A, Lundb\u00e4ck B. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J. 2008;2(Suppl1):64\u201371.","journal-title":"Clin Respir J"},{"key":"1430_CR18","volume-title":"The Minnesota code manual of electocardiographic findings : standards and procedures for measurement and classification. Boston, [Mass.]","author":"RJ Prineas","year":"1982","unstructured":"Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electocardiographic findings : standards and procedures for measurement and classification. Boston, [Mass.]. Bristol: John Wright; 1982."},{"key":"1430_CR19","doi-asserted-by":"crossref","unstructured":"Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107\u201336.","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of Spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"1430_CR22","doi-asserted-by":"crossref","unstructured":"Backman H, Lindberg A, Oden A, et al. Reference values for spirometry - report from the obstructive lung disease in northern Sweden studies. Eur Clin Respir J. 2015;2.","DOI":"10.3402\/ecrj.v2.26375"},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1164\/rccm.201512-2480OC","volume":"194","author":"FM Franssen","year":"2016","unstructured":"Franssen FM, Soriano JB, Roche N, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med. 2016;194:568\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","volume":"198","author":"KM Kunisaki","year":"2018","unstructured":"Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018;198:51\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/thx.2010.155333","volume":"66","author":"CL Chang","year":"2011","unstructured":"Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. 2011;66:764\u20138.","journal-title":"Thorax"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/heartjnl-2012-303429","volume":"99","author":"AM Neukamm","year":"2013","unstructured":"Neukamm AM, Hoiseth AD, Hagve TA, et al. High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart. 2013;99:382\u20137.","journal-title":"Heart"},{"key":"1430_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12890-016-0319-9","volume":"16","author":"A Neukamm","year":"2016","unstructured":"Neukamm A, Einvik G, Hoiseth AD, et al. The prognostic value of measurement of high-sensitive cardiac troponin T for mortality in a cohort of stable chronic obstructive pulmonary disease patients. BMC Pulm Med. 2016;16:164.","journal-title":"BMC Pulm Med"},{"key":"1430_CR28","doi-asserted-by":"crossref","unstructured":"Pizarro C, Herweg-Steffens N, et.al. Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin. Int J Chron Obstruct Pulmon Dis 2016;11:2081\u20132089.","DOI":"10.2147\/COPD.S110746"},{"issue":"1","key":"1430_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/15412550903499506","volume":"7","author":"P Lange","year":"2010","unstructured":"Lange P, Mogelvang R, Marott JL, et al. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7(1):5\u201310.","journal-title":"COPD"},{"issue":"6","key":"1430_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/hrt.80.6.570","volume":"80","author":"D De Bacquer","year":"1998","unstructured":"De Bacquer D, De Backer G, Kornitzer M, et al. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease detah in men and women. Heart. 1998;80(6):570\u20137.","journal-title":"Heart"},{"issue":"24","key":"1430_CR31","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","volume":"139","author":"P Welsh","year":"2019","unstructured":"Welsh P, Preiss D, Hayward C, et al. Cardiac troponin T and I in the general population. Circulation. 2019;139(24):2754\u201364.","journal-title":"Circulation"},{"issue":"2","key":"1430_CR32","doi-asserted-by":"publisher","first-page":"1902447","DOI":"10.1183\/13993003.02447-2019","volume":"55","author":"U Nilsson","year":"2020","unstructured":"Nilsson U, Vanfleteren LEGW. Troponin as a biomarker for mortality in stable COPD. Eur Respir J. 2020;55(2):1902447. https:\/\/doi.org\/10.1183\/13993003.02447-2019.","journal-title":"Eur Respir J"},{"key":"1430_CR33","unstructured":"World Health Organization. Autopsy rate (%) for all deaths [Internet]. Geneva: World Health Organization; 2019. Available from: https:\/\/gateway.euro.who.int\/en\/indicators\/hfa_545-6410-autopsy-rate-for-all-deaths\/. [cited 2020 14 Apr]."},{"key":"1430_CR34","doi-asserted-by":"crossref","unstructured":"Miravitlles M, Soriano J B, Garcia-Rio F, et.al. Prevalence of COPD in SPain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863\u2013868.","DOI":"10.1136\/thx.2009.115725"},{"key":"1430_CR35","doi-asserted-by":"crossref","unstructured":"Backman H, Eriksson B, R\u00f6nmark E, et.al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med 2016;114:103\u2013110.","DOI":"10.1016\/j.rmed.2016.03.013"},{"key":"1430_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00158781","volume":"9","author":"B Lundb\u00e4ck","year":"1993","unstructured":"Lundb\u00e4ck B, Stjernberg N, Nystr\u00f6m L, et al. An interview study to estimate prevalence of asthma and chronic bronchitis. The obstructive lung disease in northern Sweden study. Eur J Epidemiol. 1993;9:123\u201333.","journal-title":"Eur J Epidemiol"},{"key":"1430_CR37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jclinepi.2004.04.005","volume":"57","author":"Y Okura","year":"2004","unstructured":"Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096\u2013103.","journal-title":"J Clin Epidemiol"},{"key":"1430_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/jech-2011-200104","volume":"67","author":"M Machon","year":"2013","unstructured":"Machon M, Arriola L, Larranaga N, et al. Validity of self-reported prevalent cases of stroke and acute myocardial infarction in the Spanish cohort of the EPIC study. J Epidemiol Community Health. 2013;67:71\u20135.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1430_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1445-5994.2008.01864.x","volume":"39","author":"ELM Barr","year":"2009","unstructured":"Barr ELM, Tonkin AM, Welborn TA, et al. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J. 2009;39(1):49\u201353. https:\/\/doi.org\/10.1111\/j.1445-5994.2008.01864.x.","journal-title":"Intern Med J"},{"issue":"5","key":"1430_CR40","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/HJH.0000000000001648","volume":"36","author":"V Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves V, Andrade K, Carvalho K, et al. Accuracy of self-reported hupertension: a systematic review and meta-analysis. J Hypertens. 2018;36(5):970\u20138.","journal-title":"J Hypertens"},{"key":"1430_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1378\/chest.13-2482","volume":"147","author":"ES Ford","year":"2015","unstructured":"Ford ES. Urinary albumin-Creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function. Chest. 2015;147:56\u201367.","journal-title":"Chest"},{"issue":"5","key":"1430_CR42","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1183\/09031936.02.00023202","volume":"20","author":"JA Hardie","year":"2002","unstructured":"Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, M\u00f8rkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117\u201322.","journal-title":"Eur Respir J"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01430-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:49:48Z","timestamp":1624664988000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01430-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01430-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethical Review Board at Ume\u00e5 University, Sweden, project approval numbers: Um dnr 04\u2013045\u2009M and 2015\/446-31\u00d6.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest with regard to this manuscript.Dr. Nilsson reports personal fees from Boeringer Ingelheim, outside the submitted work. Prof. Mills reports grants from Abbott Diagnostics, personal fees from Abbott Diagnostics, grants from Siemens Healthineers, personal fees from Siemens Healthineers, personal fees from Singulex, outside the submitted work. Dr. Backman reports personal fees from Boeringer Ingelheim and Astra Zeneca, outside the submitted work. Prof. R\u00f6nmark reports grants from Swedish heart and lung foundation, grants from ALF-a regional agreement between Ume\u00e5 university and Norrbotten county council, grants from Swedish asthma and allergy foundation, grants from Norrbotten county council, grants from Nord Forsk, grants from FORMAS, grants from AstraZeneca, grants from GlaxoSmithKline, during the conduct of the study. Dr. Lindberg reports personal fees from Boehringer-Ingelheim, personal fees from AstraZeneca, personal fees from Novartis, personal fees from Active Care, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}